Current treatment concepts of gastric lymphoma;Aktuelle therapiekonzepte des magenlymphoms

Zeitschrift fur Gastroenterologie

Volumn 40, Issue SUPPL. 2, 2002, Pages 24-26

  Fischbach, W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CYCLOSPORIN; DOXORUBICIN; FLUDARABINE; PREDNISONE; VINCRISTINE;

CANCER STAGING; CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPY; ERADICATION THERAPY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; STOMACH LYMPHOMA;

EID: 0036933110     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35897     Document Type: Conference Paper

References (15)

1. Harris NL, Jaffe ES, Dibold J et al. World Health Organization Classification of Neoplastic Diseases of Hematopoetic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia November 1997. J Clin Oncol 1997; 17: 3835-3849
2. Cogliatti SB, Schmid U, Schumacher U et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology 1991; 101: 1159-1170
3. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue. Factors relevant to prognosis. Gastroenterology 1992; 102: 1628-1638
4. Fischbach W, Kolve-Goebeler ME, Greiner A. Diagnostic accuracy of endoscopic ultrasound (EUS) in the local staging of primary gastric lymphoma: Results from a prospective study comparing EUS with the pathohistological stage. Gastrointest Endosc 2002; im Druck
5. Fischbach W. Gastrointestinale lymphome. Atiologie, pathogenese und therapie. Internist 2000; 41: 831-840
6. Wotherspoon AC, Doglioni C, Diss TC et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577
7. Fischbach W, Kolve-Goebeler ME, Dragosics B. Long-Term Outcome of Patients with Localized Marginal Zone B-Cell Lymphoma of MALT Following Exclusively Helicobacter pylori Eradication Therapy. Gastroenterology 2001; 120: A746
8. Morgner A, Miehlke St, Fischbach W et al. Complete Remission of Primary High-Grade B-Cell Gastric Lymphoma after Cure of Helicobacter pylori Infection. J Clin Oncol 2001; 19: 2041-2048
9. Chen LT, Lin JT, Shyu RY et al. Prospective Study of Helicobacter pylori Eradication Therapy in Stage IE High-Grade Mucosa-Associated Lymphoid Tissue Lymphoma of the Stomach. J Clin Oncol 2001; 19: 4245-4251
10. Fischbach W, Goebeler ME, Keller R et al. Increased experience with minimal residuals of low-grade gastric MALT-type lymphoma after eradication of H. pylori and molecular findings. Gastroenterology 2002; 122: A746
11. Liu H, Ye H, Ruskone-Fourmestraux A et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroentrerology 2002; 122: 1286-1294
12. Fischbach W, Goebeler-Kolve M, Starostik P et al. Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet 2002; 360: 547-548
13. Junginger Th, Hossfeld DK, Müller RP. Diagnostik und Therapie des primären Magenlymphoms. Dtsch med Wschr 1997; 122: 1569-1572
14. Fischbach W, Dragosics B, Koelve-Goebeler ME et al. Primary gastric B-cell Lymphoma: Results of a Prospective Multicenter Study. Gastroenterology 2000; 119: 1191-1202
15. Koch P, Del Valle F, Berdel W et al. Primary gastrointestinal Non-Hodgkińs lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma. Results of the prospective German multicenter study GIT NHL 01/92. J Clin Oncol 2001; 19: 3874-3883